🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the role of combination therapy wi...
Status
Terminated
Location
Baylor College of Medicine - Methodist Hospital
Start Date
2007-08
Trial ID
NCT00521274
RATIONALE: Vaccines made from a gene-modified virus may help the body build...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00227474
The purpose of this trial is to assess the effectiveness of TroVax® compare...
Status
Completed
Location
Leeds Teaching Hospitals NHS Trust
Start Date
2013-11
Trial ID
NCT01556841
This is a clinical trial of a new treatment for prostate cancer that is a t...
Status
Completed
Location
University of Oxford
Start Date
2015-06
Trial ID
NCT02390063
Treatments Being Tested
To evaluate the efficacy and safety of Trovax and GM-CSF in patients with p...
Status
Completed
Location
The Methodist Hospital Research Institute
Start Date
2006-05
Trial ID
NCT00448409
This study will test the safety and efficacy of TroVax in patients undergoi...
Status
Completed
Location
Multiple Locations
Start Date
2004-06
Trial ID
NCT00259844
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of TroVa...
Status
Completed
Location
The Methodist Hospital
Start Date
2005-11
Trial ID
NCT00325507
The purpose of this study is to investigate whether TroVax, when added to f...
Status
Completed
Location
AZ Cancer Center
Start Date
2006-09
Trial ID
NCT00397345
Treatments Being Tested
This study is for patients with malignant mesothelioma of the lung lining (...
Status
Unknown
Location
Velindre Cancer Centre
Start Date
2012-12
Trial ID
NCT01569919
Treatments Being Tested
The purpose of this study is to test the safety of an investigational vacci...
Status
Completed
Location
Columbia Presbyterian Medical Center
Start Date
2004-08
Trial ID
NCT00083941
Treatments Being Tested